As the Indian Healthcare Sector is witnessing a number of changes for the betterment of patient safety. An amendment of Rule 3-A of the Drugs & Cosmetics Rules, 1945 by Union Health Ministry was turned down by the Drugs Technical Advisory Board (DTAB). The proposal was to announce National Institute of Biologicals (NIB) as Central Drug Laboratory for testing few vaccines line BCG vaccine. Currently CRI, Kasauli acts as the Central Drug Laboratory. The proposal of declaring NIB, Noida as Central Drug Laboratory came for discussions in the 70^th annual meeting of DTAB in which after detailed deliberations the DTAB disagreed to the proposal.

The 70^th meeting of meeting of DTAB was held in CDSCO Bhawan, New Delhi on August 18^th 2015. The CDSCO (Central Drugs Standard Control Organisation) is the Indian national regulatory body responsible for the regulation of drugs and medical devices in India. Presently the vaccines are tested at CDL, CRI Kasauli. The DTAB was reconstituted by the Union Health Ministry in this February under section 5 of Drugs and Cosmetics Rule. Director General of health services, Dr Jagdish Prasad, is the Chairman and Drugs Controller General (India) Dr G N Singh is a member secretary of the board. To know the other members of DTAB and what happened in the meeting you could view Minutes of the 70th Meeting of Drugs Technical Advisory Board.